190 related articles for article (PubMed ID: 35727061)
1. Validation of Clinical Risk Models for Clostridioides difficile
Madden GR; Petri WA; Costa DVS; Warren CA; Ma JZ; Sifri CD
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0067622. PubMed ID: 35727061
[TBL] [Abstract][Full Text] [Related]
2. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
mBio; 2020 May; 11(3):. PubMed ID: 32371595
[No Abstract] [Full Text] [Related]
3. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems.
Perry DA; Shirley D; Micic D; Patel PC; Putler R; Menon A; Young VB; Rao K
Clin Infect Dis; 2022 Jun; 74(11):2028-2035. PubMed ID: 34459885
[TBL] [Abstract][Full Text] [Related]
4. Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with
Stevens VW; Shoemaker HE; Jones MM; Jones BE; Nelson RE; Khader K; Samore MH; Rubin MA
Infect Control Hosp Epidemiol; 2020 May; 41(5):510-516. PubMed ID: 31996280
[TBL] [Abstract][Full Text] [Related]
5. Concordance of the SHEA-IDSA severity classification for Clostridium difficile infection and the ATLAS bedside scoring system in hospitalized adult patients.
Mulherin DW; Hutchison AM; Thomas GJ; Hansen RA; Childress DT
Infection; 2014 Dec; 42(6):999-1005. PubMed ID: 25129565
[TBL] [Abstract][Full Text] [Related]
6. Immune Profiling To Predict Outcome of Clostridioides difficile Infection.
Abhyankar MM; Ma JZ; Scully KW; Nafziger AJ; Frisbee AL; Saleh MM; Madden GR; Hays AR; Poulter M; Petri WA
mBio; 2020 May; 11(3):. PubMed ID: 32457246
[TBL] [Abstract][Full Text] [Related]
7. Novel Biomarkers, Including
Madden GR; Rigo I; Boone R; Abhyankar MM; Young MK; Basener W; Petri WA
Infect Immun; 2023 Apr; 91(4):e0009223. PubMed ID: 36975808
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
Miller R; Morillas JA; Brizendine KD; Fraser TG
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile.
Tilton CS; Sexton ME; Johnson SW; Gu C; Chen Z; Robichaux C; Metzger NL
Am J Health Syst Pharm; 2021 Sep; 78(18):1681-1690. PubMed ID: 33954428
[TBL] [Abstract][Full Text] [Related]
11. Surgical Infection Society Guidelines for Total Abdominal Colectomy versus Diverting Loop Ileostomy with Antegrade Intra-Colonic Lavage for the Surgical Management of Severe or Fulminant, Non-Perforated
Forrester JD; Colling KP; Diaz JJ; Faliks B; Kim PK; Tessier JM; Tung J; Huston JM
Surg Infect (Larchmt); 2022 Mar; 23(2):97-104. PubMed ID: 34619068
[No Abstract] [Full Text] [Related]
12. Cutting edges in Clostridioides difficile infections.
Durovic A; Tschudin-Sutter S
Swiss Med Wkly; 2021 Sep; 151():w30033. PubMed ID: 34652093
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a Clostridium difficile infection risk prediction model.
Dubberke ER; Yan Y; Reske KA; Butler AM; Doherty J; Pham V; Fraser VJ
Infect Control Hosp Epidemiol; 2011 Apr; 32(4):360-6. PubMed ID: 21460487
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a simple and robust model to predict 30-day mortality in patients with
Katzer KC; Hagel S; Reuken PA; Bruns T; Stallmach A
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32912845
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.
Shah MD; Balada-Llasat JM; Coe K; Reed E; Sandlund J; Pancholi P
J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32051264
[No Abstract] [Full Text] [Related]
16. Advanced age and increased CRP concentration are independent risk factors associated with Clostridioides difficile infection mortality.
Bednarska A; Bursa D; Podlasin R; Paciorek M; Skrzat-Klapaczyńska A; Porowski D; Raczyńska J; Puła J; Krogulec D; Makowiecki M; Horban A
Sci Rep; 2020 Sep; 10(1):14681. PubMed ID: 32895405
[TBL] [Abstract][Full Text] [Related]
17. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
Gentry CA; Campbell DL; Williams RJ
Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review and Meta-Analysis: A Prior Appendectomy Does Not Increase the Risk of Severe Clostridioides difficile Infection or Recurrence.
Naga YSE; Dhindsa BS; Bapaye J; Tun KM; Dhaliwal A; Ramai D; Saghir SM; Chandan S; Adler DG
Dig Dis Sci; 2023 Sep; 68(9):3714-3720. PubMed ID: 37402978
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning-Based Prediction Models for Clostridioides difficile Infection: A Systematic Review.
Tariq R; Malik S; Redij R; Arunachalam S; Faubion WA; Khanna S
Clin Transl Gastroenterol; 2024 Jun; 15(6):e1. PubMed ID: 38661188
[TBL] [Abstract][Full Text] [Related]
20. Does accepted definition of Clostridioides difficile infection (CDI) severity predict poor outcomes in older adults?
Atamna A; Babich T; Margalit I; Avni T; Ben Zvi H; Raz NE; Yahav D; Bishara J
Aging Clin Exp Res; 2022 Mar; 34(3):583-589. PubMed ID: 34426944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
